AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Correlation Between Gut Microbiota, Metabolites, and Diabetic Complications: A Two‐Sample Mendelian Randomization Study

Jiaxi Fang1Leilei Zhai2Chan Huang3Liqin Li4Yong Wang5( )Jiaojiao Fan6( )Wei Zhou4,7 ( )
Department of Ultrasound, Taizhou Central Hospital, Taizhou, China
The First Department of Gastroenterology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
TCM Key Laboratory Cultivation Base of Zhejiang Province for the Development and Clinical Transformation of Immunomodulatory Drugs, Huzhou Central Hospital, Huzhou, China
Department of Internal Medicine, Yanbian University Hospital, Yanji, China
Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Clinical Center of Pediatric Nephrology of Henan Province, Zhengzhou, China
Department of Nephrology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China
Show Author Information

Abstract

Background

Given the observed links between the gut microbiota and diabetic complications in epidemiological studies, we used a two‐sample Mendelian randomization (MR) method to assess causality, considering the role of microbial metabolic pathways.

Methods

We selected genetic variants associated with gut microbiota (n = 18,340) and microbiota‐derived metabolites (n = 7824) from genome‐wide association studies. Summary statistics for diabetic nephropathy (DN), diabetic neuropathy (DNe), diabetic peripheral vascular disease (DPVD), and diabetic retinopathy (DR) were obtained from FinnGen and CKDGen genome‐wide association studies databases. In primary causality assessment, we used inverse‐variance weighted analysis supplemented with MR‐Egger and weighted median methods. We conducted sensitivity analyses (Cochran's Q, MR‐Egger intercept, MR‐Pleiotropy RESidual Sum and Outlier, leave‐one‐out) to ensure robustness.

Results

Genetically increased genus.Eubacteriumhallii was suggestively linked to higher diabetic nephropathy risk. Eubacteriumrectale and Eubacteriumventriosum showed protective associations. The genetically increased abundance of RuminococcaceaeUCG005, Butyrivibrio, and Streptococcus at the genus level was potentially associated with a protective effect in DNe. However, a significant positive relation was found between Actinomyces and DNe. As for diabetic peripheral vascular disease, Eubacteriumrectale, Ruminococcusgnavus, and LachnospiraceaeUCG008 were risk factors, whereas Coprococcus1, Hungatella, and LachnospiraceaeUCG001 were protective factors. A significant casualty with genus.Odoribacter and Sellimonas was causally linked to diabetic retinopathy. All the above findings were robust across several sensitivity analyses. Six gut metabolites also showed suggestive associations with complications.

Conclusions

Our study first detected causal relationships among gut microbiota, gut metabolites, and diabetic complications. Our findings may provide new targets for treatment and offer valuable insights for further studies into the underlying mechanisms.

Graphical Abstract

Fang et al. demonstrate a significant causal relationship among gut microbiota, gut metabolites, and diabetic complications, highlighting a biological link underlying mechanisms of diabetic vascular diseases. These findings provide important implications for future therapeutic strategy and risk prediction. The graphical abstract was created in BioRender. Fang, J. (2026) https://BioRender.com/k5l4cse.

Electronic Supplementary Material

Download File(s)
med-4-2-196_ESM1.docx (103.1 KB)
Image
med-4-2-196_ESM2.jpg

References

【1】
【1】
 
 
Medicine Advances
Pages 196-205

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Fang J, Zhai L, Huang C, et al. Correlation Between Gut Microbiota, Metabolites, and Diabetic Complications: A Two‐Sample Mendelian Randomization Study. Medicine Advances, 2026, 4(2): 196-205. https://doi.org/10.1002/med4.70053

10

Views

0

Downloads

0

Crossref

Received: 21 June 2025
Revised: 31 July 2025
Accepted: 24 August 2025
Published: 12 March 2026
© 2026 The Author(s). Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.